Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration - PubMed (original) (raw)
Review
. 2015 May 12;10(Suppl 1):43-60.
doi: 10.4137/BMI.S20062. eCollection 2015.
Affiliations
- PMID: 25983552
- PMCID: PMC4429653
- DOI: 10.4137/BMI.S20062
Review
Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration
Caroline P Addington et al. Biomark Insights. 2015.
Abstract
Traumatic brain injury (TBI) affects 5.3 million Americans annually. Despite the many long-term deficits associated with TBI, there currently are no clinically available therapies that directly address the underlying pathologies contributing to these deficits. Preclinical studies have investigated various therapeutic approaches for TBI: two such approaches are stem cell transplantation and delivery of bioactive factors to mitigate the biochemical insult affiliated with TBI. However, success with either of these approaches has been limited largely due to the complexity of the injury microenvironment. As such, this review outlines the many factors of the injury microenvironment that mediate endogenous neural regeneration after TBI and the corresponding bioengineering approaches that harness these inherent signaling mechanisms to further amplify regenerative efforts.
Keywords: controlled release; stem cells; transplantation; traumatic brain injury.
Figures
Figure 1
Schematic depicting the active cell types and their role in the pathophysiology of TBI.
Figure 2
Temporal and spatial pro-regenerative signaling patterns following TBI. (A) Within the injury penumbra, expression increases for SDF-1α, VEGF, EGF, FGF, and BDNF in unique temporal patterns. (B) Expression of EGF and BDNF has also been observed to increase in the hippocampus after injury.
Figure 3
Temporal and spatial inflammatory cytokine signaling patterns following TBI. (A) TNF expression increases for 1 week after injury in the injury penumbra, while (B, C) IL-6 expression has been shown to increase in the hippocampus and blood for 1 week after injury. (A–C) A more acute increase in expression has been observed for IL-1β in the injury penumbra, hippocampus, and blood.
Figure 4
The route of delivery to the central nervous system plays a critical role in determining the spatial and temporal distribution of infused agents. (A) Demonstrates conventional means of bypassing the blood–brain barrier, which includes the intracortical, intracerebroventricular, and intrathecal routes. Each route of delivery has its own strengths and weaknesses, and thus outcome of therapy depends heavily on proper selection of the means of administering the therapeutic agent/construct. Intrathecal injections are made directly in the subarachnoid space of the spinal cord, whereas intracerebroventricular and intracortical injections refer to infusion of drugs directly into the ventricles or into the cortical interstitium, respectively. Efficiency of drug accumulation in the CNS is very low, even in the cases where the blood–brain barrier is bypassed. This is especially a challenge for applications where high drug concentrations are required in a specific portion of the brain. (B) Bolus injections of a therapeutic have rather transient effects with minimal time in the therapeutic threshold window; however, (idealized) controlled release of bioactive molecules may achieve sustained biochemical effects throughout the therapeutic time window.
Similar articles
- Stem Cell Therapy in Brain Trauma: Implications for Repair and Regeneration of Injured Brain in Experimental TBI Models.
Rolfe A, Sun D. Rolfe A, et al. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 42. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 42. PMID: 26269908 Free Books & Documents. Review. - The use of bioactive matrices in regenerative therapies for traumatic brain injury.
Tan HX, Borgo MPD, Aguilar MI, Forsythe JS, Taylor JM, Crack PJ. Tan HX, et al. Acta Biomater. 2020 Jan 15;102:1-12. doi: 10.1016/j.actbio.2019.11.032. Epub 2019 Nov 18. Acta Biomater. 2020. PMID: 31751809 Review. - The Potential of Stem Cells in Treatment of Traumatic Brain Injury.
Weston NM, Sun D. Weston NM, et al. Curr Neurol Neurosci Rep. 2018 Jan 25;18(1):1. doi: 10.1007/s11910-018-0812-z. Curr Neurol Neurosci Rep. 2018. PMID: 29372464 Free PMC article. Review. - Stem cell biology in traumatic brain injury: effects of injury and strategies for repair.
Richardson RM, Singh A, Sun D, Fillmore HL, Dietrich DW 3rd, Bullock MR. Richardson RM, et al. J Neurosurg. 2010 May;112(5):1125-38. doi: 10.3171/2009.4.JNS081087. J Neurosurg. 2010. PMID: 19499984 Review. - IGF-1/IGF-R Signaling in Traumatic Brain Injury: Impact on Cell Survival, Neurogenesis, and Behavioral Outcome.
Madathil SK, Saatman KE. Madathil SK, et al. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 7. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 7. PMID: 26269893 Free Books & Documents. Review.
Cited by
- Modulating Mitochondrial Dynamics Mitigates Cognitive Impairment in Rats with Myocardial Infarction.
Jinawong K, Piamsiri C, Apaijai N, Maneechote C, Arunsak B, Nawara W, Thonusin C, Pintana H, Chattipakorn N, Chattipakorn SC. Jinawong K, et al. Curr Neuropharmacol. 2024;22(10):1749-1760. doi: 10.2174/1570159X22666240131114913. Curr Neuropharmacol. 2024. PMID: 38362882 Free PMC article. - Cellular and molecular mechanisms in vascular repair after traumatic brain injury: a narrative review.
Zhao ZA, Yan L, Wen J, Satyanarayanan SK, Yu F, Lu J, Liu YU, Su H. Zhao ZA, et al. Burns Trauma. 2023 Sep 4;11:tkad033. doi: 10.1093/burnst/tkad033. eCollection 2023. Burns Trauma. 2023. PMID: 37675267 Free PMC article. Review. - Research progress of fibroblast growth factor in nervous system diseases.
Huang W, Qiu W, Chen K, Ye S, Wang D, Hu J, Xu H, Lin L, Li X. Huang W, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Dec 25;51(6):738-749. doi: 10.3724/zdxbyxb-2022-0180. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36915973 Free PMC article. English. - Novel Electrode Designs for Neurostimulation in Regenerative Medicine: Activation of Stem Cells.
Iwasa SN, Shi HH, Hong SH, Chen T, Marquez-Chin M, Iorio-Morin C, Kalia SK, Popovic MR, Naguib HE, Morshead CM. Iwasa SN, et al. Bioelectricity. 2020 Dec 1;2(4):348-361. doi: 10.1089/bioe.2020.0034. Epub 2020 Dec 16. Bioelectricity. 2020. PMID: 34471854 Free PMC article. Review. - An implantable human stem cell-derived tissue-engineered rostral migratory stream for directed neuronal replacement.
O'Donnell JC, Purvis EM, Helm KVT, Adewole DO, Zhang Q, Le AD, Cullen DK. O'Donnell JC, et al. Commun Biol. 2021 Jul 15;4(1):879. doi: 10.1038/s42003-021-02392-8. Commun Biol. 2021. PMID: 34267315 Free PMC article.
References
- Thurman D, Guerrero J. Trends in hospitalization associated with traumatic brain injury. JAMA. 1999;282(10):954–7. - PubMed
- Coronado VG, McGuire LC, Sarmiento K, et al. Trends in traumatic brain injury in the U.S. and the public health response: 1995–2009. J Safety Res. 2012;43(4):299–307. - PubMed
- Arbour RB. Traumatic brain injury pathophysiology, monitoring, and mechanism-based care. Crit Care Nurs Clin North Am. 2013;25(2):297–319. - PubMed
- Selassie AW, Zaloshnja E, Langlois JA, Miller T, Jones P, Steiner C. Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehabil. 2008;23(2):123–31. - PubMed
- Silver JM, McAllister TW, Yudofsky SC. Textbook of Traumatic Brain Injury. American Psychiatric Publishing, Inc; Arlington, VA: 2011.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials